These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36691350)

  • 1. The phenotypic and genotypic features of Chinese patients with oculopharyngeal muscular dystrophy.
    Lin F; Yang K; Lin MT; Zheng FZ; Chen L; Ding YL; Ye ZX; Lin X; Wang N; Wang ZQ
    Ann Clin Transl Neurol; 2023 Mar; 10(3):426-439. PubMed ID: 36691350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
    van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
    J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.
    Goh KJ; Wong KT; Nishino I; Minami N; Nonaka I
    Neuromuscul Disord; 2005 Mar; 15(3):262-4. PubMed ID: 15725589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oculopharyngeal muscular dystrophy --an under-diagnosed disease in China? Report a China-born Chinese with PABPN1 mutation and epidemiology review of the literature.
    Chien YY
    J Formos Med Assoc; 2012 Jul; 111(7):397-402. PubMed ID: 22817818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
    Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
    Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
    Nadaj-Pakleza A; Richard P; Lusakowska A; Gajewska J; Jamrozik Z; Kostera-Pruszczyk A; Kwieciński H; Kamińska A
    Neurol Neurochir Pol; 2009; 43(2):113-20. PubMed ID: 19484687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.
    Roth F; Dhiab J; Boulinguiez A; Mouigni HR; Lassche S; Negroni E; Muraine L; Marhic A; Oliver A; Lainé J; Rouche A; O'Ferrall EK; van Engelen B; Ottenheijm C; Greif H; Blumen S; Lacau St Guily J; Perie S; Butler-Browne G; Mouly V; Trollet C
    Acta Neuropathol; 2022 Dec; 144(6):1157-1170. PubMed ID: 36197469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population.
    Shan J; Chen B; Lin P; Li D; Luo Y; Ji K; Zheng J; Yuan Y; Yan C
    Neuromolecular Med; 2014 Dec; 16(4):782-6. PubMed ID: 25283883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy.
    Galimberti V; Tironi R; Lerario A; Scali M; Del Bo R; Rodolico C; Brizzi T; Gibertini S; Maggi L; Mora M; Toscano A; Comi GP; Sciacco M; Moggio M; Peverelli L
    Eur J Neurol; 2020 Apr; 27(4):709-715. PubMed ID: 31769567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation.
    Nishii YS; Noto YI; Yasuda R; Kitaoji T; Ashida S; Tanaka E; Minami N; Nishino I; Mizuno T
    BMC Neurol; 2021 Jul; 21(1):265. PubMed ID: 34225694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy.
    Bae JS; Ki CS; Kim JW; Kim BJ
    J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
    Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
    Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.
    Fan X; Messaed C; Dion P; Laganiere J; Brais B; Karpati G; Rouleau GA
    Can J Neurol Sci; 2003 Aug; 30(3):244-51. PubMed ID: 12945950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy.
    Müller T; Deschauer M; Kolbe-Fehr F; Zierz S
    J Neurol; 2006 Jul; 253(7):892-5. PubMed ID: 16619122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oculopharyngeal muscular dystrophy among Bulgarian Jews: a new cluster?
    Blumen SC; Kesler A; Dabby R; Shalev S; Khayat M; Almog Y; Zoldan J; Benninger F; Drory VE; Gurevich M; Sadeh M; Brais B; Braverman I
    Isr Med Assoc J; 2013 Dec; 15(12):748-52. PubMed ID: 24449978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy.
    Ribot C; Soler C; Chartier A; Al Hayek S; Naït-Saïdi R; Barbezier N; Coux O; Simonelig M
    PLoS Genet; 2022 Jan; 18(1):e1010015. PubMed ID: 35025870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
    Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
    Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.